The role of microRNAs in the biology of rare diseases

International Journal of Molecular Sciences

Volumn 12, Issue 10, 2011, Pages 6733-6742

  Salvatore, Marco ^a   Magrelli, Armando ^a   Taruscio, Domenica ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Biomarker; Hailey hailey disease; Hepatoblastoma; MicroRNA; Multiple osteochondromas; Rare disease; Rett syndrome; Sezary syndrome

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 122A; MICRORNA 130; MICRORNA 133; MICRORNA 140; MICRORNA 145; MICRORNA 146A; MICRORNA 146B; MICRORNA 181; MICRORNA 18A; MICRORNA 195; MICRORNA 199A; MICRORNA 199B; MICRORNA 206; MICRORNA 21; MICRORNA 214; MICRORNA 221; MICRORNA 233; MICRORNA 29; MICRORNA 296; MICRORNA 29B; MICRORNA 31; MICRORNA 329; MICRORNA 342; MICRORNA 382; MICRORNA 409; MICRORNA 486; MICRORNA 92; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL EFFECTIVENESS; COPY NUMBER VARIATION; DIAGNOSTIC PROCEDURE; DOWN REGULATION; DUCHENNE MUSCULAR DYSTROPHY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAILEY HAILEY DISEASE; HEPATOBLASTOMA; HEREDITARY MULTIPLE EXOSTOSIS; HUMAN; PROGNOSIS; RARE DISEASE; RETT SYNDROME; RNA ANALYSIS; SEZARY SYNDROME; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION; EXOSTOSES, MULTIPLE HEREDITARY; GENETICS; METABOLISM; MUSCULAR DYSTROPHY, DUCHENNE; PEMPHIGUS, BENIGN FAMILIAL; RARE DISEASES;

AMYOTROPHIC LATERAL SCLEROSIS; BIOLOGICAL MARKERS; EXOSTOSES, MULTIPLE HEREDITARY; HEPATOBLASTOMA; HUMANS; MICRORNAS; MUSCULAR DYSTROPHY, DUCHENNE; PEMPHIGUS, BENIGN FAMILIAL; RARE DISEASES; RETT SYNDROME; SEZARY SYNDROME;

EID: 80055028582     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12106733     Document Type: Article

References (41)

1. European Parliament and the Council. Regulation (EC) 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products. Off. J. Eur. Communities 2000, 22, L18:1-L18:5.
2. Eurordis. EurordisCare2: survey of diagnostic delays, 8 diseases, Europe. Available online: http://archive.eurordis.org/article.php3?id_article=454 (accessed on 9 October 2011).
3. Abbott, A. Rare-disease project has global ambitions. Nature 2011, 472, 17.
4. Pheasant, M.; Mattick, J.S. Raising the estimate of functional human sequences. Genome Res. 2007, 17, 1245-1253.
5. Soifer, H.S.; Rossi, J.J.; Saetrom, P. MicroRNAs in disease and potential therapeutic applications. Mol. Ther. 2007, 15, 2070-2079.
6. Garzon, R.; Calin, G.A.; Croce, C.M. MicroRNAs in cancer. Annu. Rev. Med. 2009, 60, 167-179.
7. Calin, G.A.; Croce, C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6, 857-866.
8. Negrini, M.; Nicoloso, M.S.; Calin, G.A. MicroRNAs and cancer-new paradigms in molecular oncology. Curr. Opin. Cell Biol. 2009, 21, 470-479.
9. Deng, S.; Calin, G.A.; Croce, C.M. Mechanisms of microRNA deregulation in human cancer. Cell Cycle 2008, 7, 2643-2646.
10. de la Chapelle, A.; Jazdzewski, K. MicroRNAs in thyroid cancer. J. Clin. Endocrinol. Metab. 2011, doi:10.1210/jc.2011-1004.
11. Mitchell, P.S.; Parkin, R.K.; Kroh, E.M.; Fritz, B.R.; Wyman, S.K.; Pogosova-Agadjanyan, E.L.; Peterson, A.; Noteboom, J.; O'Briant, K.C.; Allen, A.; et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. USA 2008, 105, 10513-10518.
12. Marcucci, G.; Radmacher, M.D.; Maharry, K.; Mrózek, K.; Ruppert, A.S.; Paschka, P.; Vukosavljevic, T.; Whitman, S.P.; Baldus, C.D.; Langer, C.; et al. MicroRNA expression in cytogenetically normal acute myeloid leukemia. N. Engl. J. Med. 2008, 358, 1919-1928.
13. Szulwach, K.E.; Jin, P.; Alisch, R.S. Noncoding RNAs in mental retardation. Clin. Genet. 2009, 75, 209-219.
14. Bandiera, S.; Hatem, E.; Lyonnet, S.; Henrion-Caude, A. microRNAs in diseases: From candidate to modifier genes. Clin. Genet. 2010, 77, 306-313.
15. Duan, S.; Mi, S.; Zhang, W.; Dolan, M.E. Comprehensive analysis of the impact of SNPs and CNVs on human microRNAs and their regulatory genes. RNA Biol. 2009, 6, 412-425.
16. Vidal, M.; Cusick, M.E.; Barabási, A.L. Interactome networks and human disease. Cell. 2011, 144, 986-998.
17. Cacchiarelli, D.; Legnini, I.; Martone, J.; Cazzella, V.; D'Amico, A.; Bertini, E.; Bozzoni, I. miRNAs as serum biomarkers for Duchenne muscular dystrophy. EMBO Mol. Med. 2011, 3, 258-265.
18. Mizuno, H.; Nakamura, A.; Aoki, Y.; Ito, N.; Kishi, S.; Yamamoto, K.; Sekiguchi, M.; Takeda, S.; Hashido, K. Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy. PLoS One 2011, 6, doi:10.1371/journal.pone.0018388.
19. Naguibneva, I.; Ameyar-Zazoua, M.; Polesskaya, A.; Ait-Si-Ali, S.; Groisman, R.; Souidi, M.; Cuvellier, S.; Harel-Bellan, A. The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation. Nat. Cell Biol. 2006, 8, 278-284.
20. Chen, J.F.; Mandel, E.M.; Thomson, J.M.; Wu, Q.; Callis, T.E.; Hammond, S.M.; Conlon, F.L.; Wang, D.-Z. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 2006, 38, 228-233.
21. Cacchiarelli, D.; Martone, J.; Girardi, E.; Cesana, M.; Incitti, T.; Morlando, M.; Nicoletti, C.; Santini, T.; Sthandier, O.; Barberi, L.; et al. MicroRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin/nNOS pathway. Cell Metab. 2010, 12, 341-351.
22. van Rooij, E.; Sutherland, L.B.; Thatcher, J.E.; DiMaio, J.M.; Naseem, R.H.; Marshall, W.S.; Hill, J.A.; Olson, E.N. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc. Natl. Acad. Sci. USA 2008, 105, 13027-13032.
23. Eisenberg, I.; Eran, A.; Nishino, I.; Moggio, M.; Lamperti, C.; Amato, A.A.; Lidov, H.G.; Kang, P.B.; North, K.N.; Mitrani-Rosenbaum, S.; et al. Distinctive patterns of microRNA expression in primary muscular disorders. Proc. Natl. Acad. Sci. USA 2007, 104, 17016-17021.
24. Greco, S.; De Simone, M.; Colussi, C.; Zaccagnini, G.; Fasanaro, P.; Pescatori, M.; Cardani, R.; Perbellini, R.; Isaia, E.; Sale, P.; et al. Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia. FASEB J. 2009, 23, 3335-3346.
25. Yuasa, K.; Hagiwara, Y.; Ando, M.; Nakamura, A.; Takeda, S.; Hijikata, T. MicroRNA-206 is highly expressed in newly formed muscle fibers: implications regarding potential for muscle regeneration and maturation in muscular dystrophy. Cell Struct. Funct. 2008, 33, 163-169.
26. Williams, A.H.; Valdez, G.; Moresi, V.; Qi, X.; McAnally, J.; Elliott, J.L.; Bassel-Duby, R.; Sanes, J.R.; Olson, E.N. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 2009, 326, 1549-1554.
27. Werdlow, S.H.; Campo, E.; Harris, N.L.; Jaffe, E.S.; Pileri, S.A.; Stein, H.; Thiele, J.; Vardiman, J.W. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues, 4th ed.; International Agency for Research on Cancer Press: Lyon, France, 2008; Volume 2.
28. Ballabio, E.; Mitchell, T.; van Kester, M.S.; Taylor, S.; Dunlop, H.M.; Chi, J.; Tosi, I.; Vermeer, M.H.; Tramonti, D.; Saunders, N.J.; et al. MicroRNA expression in Sezary syndrome: Identification, function, and diagnostic potential. Blood 2010, 116, 1105-1113.
29. Narducci, M.G.; Arcelli, D.; Picchio, M.C.; Lazzeri, C.; Pagani, E.; Sampogna, F.; Scala, E.; Fadda, P.; Cristofoletti, C.; Facchiano, A.; et al. MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome. Cell Death Dis. 2011, 2, e151.
30. van der Fits, L.; van Kester, M.S.; Qin, Y.; Out-Luiting, J.J.; Smit, F.; Zoutman, W.H.; Willemze, R.; Tensen, C.P.; Vermeer, M.H. MicroRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in Sézary syndrome. J. Invest. Dermatol. 2011, 131, 762-768.
31. Urdinguio, R.G.; Fernandez, A.F.; Lopez-Nieva, P.; Rossi, S.; Huertas, D.; Kulis, M.; Liu, C.-G.; Croce, C.; Calin, G.A.; Esteller, M. Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome. Epigenetics 2010, 5, 656-663.
32. Zuntini, M.; Salvatore, M.; Pedrini, E.; Parra, A.; Sgariglia, F.; Magrelli, A.; Taruscio, D.; Sangiorgi, L. MicroRNA profiling of multiple osteochondromas: Identification of disease-specific and normal cartilage signatures. Clin. Genet. 2010, 78, 507-516.
33. Xu, N.; Brodin, P.; Wei, T.; Meisgen, F.; Eidsmo, L.; Nagy, N.; Kemeny, L.; Ståhle, M.; Sonkoly, E.; Pivarcsi, A. MiR-125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2. J. Invest. Dermatol. 2011, 131, 1521-1529.
34. Sun, D.; Lee, Y.S.; Malhotra, A.; Kim, H.K.; Matecic, M.; Evans, C.; Jensen, R.V.; Moskaluk, C.A.;Dutta, A. miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation. Cancer Res. 2011, 71, 1313-1324.
35. Shin, K.H.; Bae, S.D.; Hong, H.S.; Kim, R.H.; Kang, M.K.; Park, N.H. miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras. Biochem. Biophys. Res. Commun. 2011, 404, 896-902.
36. Landais, S.; Landry, S.; Legault, P.; Rassart, E. Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res. 2007, 67, 5699-5707.
37. Cialfi, S.; Oliviero, C.; Ceccarelli, S.; Marchese, C.; Barbieri, L.; Biolcati, G.; Uccelletti, D.; Palleschi, C.; Barboni, L.; De Bernardo, C.; et al. Complex multipathways alterations and oxidative stress are associated with Hailey-Hailey disease. Br. J. Dermatol. 2010, 162, 518-526.
38. Manca, S.; Magrelli, A.; Cialfi, S.; Lefort, K.; Ambra, R.; Alimandi, M.; Biolcati, G.; Uccelletti, D.; Palleschi, C.; Screpanti, I.; et al. Oxidative stress activation of miR-125b is part of the molecular switch for Hailey-Hailey disease manifestation. Exp. Dermatol. 2011, doi:10.1111/j.1600-0625.2011.01359.x
39. Tili, E.; Michaille, J.J.; Cimino, A.; Costinean, S.; Dumitru, C.D.; Adair, B.; Fabbri, M.; Alder, H.; Liu, C.G.; Calin, G.A.; et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J. Immunol. 2007, 179, 5082-5089.
40. Magrelli, A.; Azzalin, G.; Salvatore, M. Altered microRNA expression patterns in hepatoblastoma patients. Transl. Oncol. 2009, 2, 157-163.
41. von Frowein, J.; Pagel, P.; Kappler, R.; von Schweinitz, D.; Roscher, A.; Schmid, I. MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma. Hepatology 2011, 53, 833-842.